SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending as investors debate whether the asset is finally showing signs of a long-term recovery or remains caught in a cycle of dilution and price suppression. While some community members point to positive technical setups and the potential impact of future regulatory clarity, others express skepticism, citing years of stagnant performance and the token's struggle to maintain key support levels.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant stock volatility and investor frustration, driven by the recent appointment of a new CEO and lingering skepticism regarding the company's valuation relative to its Duchenne muscular dystrophy portfolio. Community sentiment is deeply polarized, with many investors pointing to an apparent disconnect between the company's approved therapies and its distressed stock price, leading to intense debates over potential buyout scenarios versus the long-term potential of its siRNA pipeline.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is currently attracting significant community attention as it trades alongside other major utility tokens, with investors closely watching for signs of institutional adoption and regulatory progress. While some participants express frustration over recent price volatility, others are aggressively accumulating, citing long-term potential in enterprise infrastructure and anticipation of a broader market turnaround.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant volatility and social media attention as investors debate its potential for a short squeeze, driven by a high short interest and conflicting views on its valuation versus its enterprise growth. While some community members are betting on a recovery fueled by AI product integration and recent institutional upgrades, others remain skeptical, citing executive insider selling and persistent concerns over the stock's post-IPO performance.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is gaining momentum as investors weigh its strengthening commercial position against persistent speculation regarding its potential as an M&A target. The community is actively debating the stock's long-term value, focusing on recent research facility restructuring, high short interest levels, and institutional activity that signals a potential pivot toward a more aggressive growth or acquisition-led strategy.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors digest significant partnerships, including a recent collaboration with Vertex Pharmaceuticals, which has fueled optimism regarding the platform's long-term validation and commercial potential. While the community is actively debating the company's valuation, clinical data milestones for its internal pipeline, and potential for a short squeeze, sentiment remains divided between long-term holders encouraged by platform growth and skeptics focused on historical stock performance and lack of consistent shareholder returns.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing (RGTI) is trending as investors debate the impact of increased government quantum funding and recent sector-wide volatility. The community remains deeply divided, with some highlighting the stock's long-term potential and new partnership catalysts while others voice significant concerns regarding persistent cash burn, shareholder dilution, and the overall speculative nature of pure-play quantum stocks.

Jersey Mike's Subs, Inc. engages in franchising fast casual, submarine-style sandwich restaurants specializing in authentic, hand-crafted, and craveable subs. The company was founded by Peter Cancro in 1956 and is headquartered in Tinton Falls, DE.

Jersey Mike`s Subs Inc. - Ordinary Shares - Class A

Jersey Mike's Subs recently made its public market debut on the NYSE following a highly anticipated IPO that saw strong institutional demand. While some community members are excited about the brand's rapid expansion and growth potential, others are actively debating its valuation, the impact of public ownership on food quality, and its initial performance compared to other fast-casual restaurant chains.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors react to the arrival of major turbine components at the Port of Houston, which serves as a critical milestone for its Project Matador energy campus. The community is actively debating the potential for an imminent anchor tenant agreement, with many pointing to significant executive compensation incentives tied to a late-July signing deadline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
